We do this by combining industry expertise with rapid test technology innovation and best-in-class automation.
Abingdon Health is a technology-enabled lateral flow diagnostics company providing leading-edge rapid testing solutions to a multi-industry, global client base. Abingdon Health provides lateral flow assay development and smartphone reader solutions alongside Europe’s largest rapid test manufacturing capacity.
A multi-disciplinary team forms the foundations of our services and a partnership-led approach alongside a focus on operational excellence produces reliable products irrespective of their complexity. Established supply chain and manufacturing processes are tailored to assay specifications and market demand for continuity of supply.
Abingdon Health is the lead manufacturer of AbC-19TM, a rapid test for the detection of IgG neutralising antibodies to SARS-CoV-2 (COVID-19). The test was developed by Abingdon Health on behalf of the UK Rapid Test Consortium (UK-RTC).
Abingdon Health is headquartered in York, UK, with additional sites across the UK in Doncaster and Birmingham.
The health and wellbeing of people is at the heart of everything Abingdon Health does.
Learn about Abingdon Health here.
Click to learn more about our bespoke and customer focused lateral flow assay development service
See how we meet different customer needs with our low- to high-volume lateral flow contract manufacturing capabilities